Pill-shaped crystal award recognizing excellence in safety and operational performance. (24AZH129)
Pill-shaped crystal award recognizing excellence in safety and operational performance. (24AZH129)
Custom Lucite, incorporating an embedded vial of Imdelltra, celebrating the approval of the drug by the Food and Drug Administration (FDA). Developed by Amgen, Imdelltra treats small cell lung cancer, a condition that afflicts about 35,000 Americans annually. (24ALJ148)
Lucite deal toy, featuring a reverse-etched lasered logo, marking the acquisition of Alpine Laser. The company specializes in laser technology for medical devices. (24AKL389)
Custom Lucite celebrating the first-in-human trial of SOR 102, a treatment for nflammatory bowel disease. The drug was developed by Utah-based Sorriso Pharmaceuticals. (23AKL435)
Crystal financial tombstone celebrating Series B financing for Nuvig Therapeutics. The immune drug developer is based in Menlo Park, California. (24ALJ345)
Laboratory-themed crystal financial tombstone commemorating a capital raise by Sartorius Stedim Biotech. The biopharmaceutical company is based in Aubagne, France. (SO24LJW040)
Capsule-themed custom crystal commemoratng the first patient dosed stage in the development of ACR-2316. The cancer treatment was developed by Acrivon Therapeutics, a Watertown, Massachusetts-based biopharmaceutical company. (24AKL397)